Archive: 28/07/2014
Potassium pills, implantable device help heart-failure patients cope with summer heat
Patients with heart failure engage in a delicate balancing act all year, taking care not to drink too much liquid because the weakened heart muscle cannot cope with excess fluid.
Jul 28, 2014
Hepatitis C virus genotype 1 is most prevalent worldwide
In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal ...
Jul 28, 2014
1 in 3000 blood donors in England infected with hepatitis E
The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around ...
Jul 28, 2014
Tentative deal reached on VA reform
(AP)—The chairmen of the House and Senate Veterans Affairs committees have reached a tentative agreement on a plan to fix a veterans' health care system scandalized by long patient wait times and falsified records covering ...
Jul 28, 2014
Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke
A new in vitro study has revealed that nicotine and cotinine, a metabolite of nicotine, can potentially inhibit DNA damage caused by a certain carcinogen in smoke.
Jul 28, 2014
Online information most cost-effective means of increasing MMR uptake, research finds
Giving parents access to a website containing information about the measles, mumps and rubella (MMR) vaccine is the most cost-effective way of increasing its uptake, new University of Leeds research has found.
Jul 28, 2014
New oral drug regimens cure hardest-to-treat hepatitis C
Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according ...
Jul 28, 2014
Kidney transplant drug halves the early risk of rejection and allows less toxic treatment
Oxford University scientists have shown that a powerful drug given at the time of a kidney transplant operation not only halves the early risk of rejection, but that it also allows a less toxic regimen of anti-rejection drugs ...
Jul 28, 2014